117 related articles for article (PubMed ID: 1995903)
21. 4'-Hydroxy-3-methoxyflavones with potent antipicornavirus activity.
De Meyer N; Haemers A; Mishra L; Pandey HK; Pieters LA; Vanden Berghe DA; Vlietinck AJ
J Med Chem; 1991 Feb; 34(2):736-46. PubMed ID: 1847431
[TBL] [Abstract][Full Text] [Related]
22. Tyrosinase inhibition by some flavonoids: Inhibitory activity, mechanism by in vitro and in silico studies.
Şöhretoğlu D; Sari S; Barut B; Özel A
Bioorg Chem; 2018 Dec; 81():168-174. PubMed ID: 30130649
[TBL] [Abstract][Full Text] [Related]
23. Sulfonylbenzoyl-nitrostyrenes: potential bisubstrate type inhibitors of the EGF-receptor tyrosine protein kinase.
Traxler PM; Wacker O; Bach HL; Geissler JF; Kump W; Meyer T; Regenass U; Roesel JL; Lydon N
J Med Chem; 1991 Aug; 34(8):2328-37. PubMed ID: 1652014
[TBL] [Abstract][Full Text] [Related]
24. Human urotensin II-induced aorta ring contractions are mediated by protein kinase C, tyrosine kinases and Rho-kinase: inhibition by somatostatin receptor antagonists.
Rossowski WJ; Cheng BL; Taylor JE; Datta R; Coy DH
Eur J Pharmacol; 2002 Mar; 438(3):159-70. PubMed ID: 11909607
[TBL] [Abstract][Full Text] [Related]
25. Double-edged sword effect of biochanin to inhibit nuclear factor kappaB: suppression of serine/threonine and tyrosine kinases.
Manna SK
Biochem Pharmacol; 2012 May; 83(10):1383-92. PubMed ID: 22387535
[TBL] [Abstract][Full Text] [Related]
26. Tyrosine kinase inhibitors. 13. Structure-activity relationships for soluble 7-substituted 4-[(3-bromophenyl)amino]pyrido[4,3-d]pyrimidines designed as inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor.
Thompson AM; Murray DK; Elliott WL; Fry DW; Nelson JA; Showalter HD; Roberts BJ; Vincent PW; Denny WA
J Med Chem; 1997 Nov; 40(24):3915-25. PubMed ID: 9397172
[TBL] [Abstract][Full Text] [Related]
27. Identification of tricyclic analogs related to ellagic acid as potent/selective tyrosine protein kinase inhibitors.
Dow RL; Chou TT; Bechle BM; Goddard C; Larson ER
J Med Chem; 1994 Jul; 37(14):2224-31. PubMed ID: 7518523
[TBL] [Abstract][Full Text] [Related]
28. Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor.
Huang YT; Hwang JJ; Lee PP; Ke FC; Huang JH; Huang CJ; Kandaswami C; Middleton E; Lee MT
Br J Pharmacol; 1999 Nov; 128(5):999-1010. PubMed ID: 10556937
[TBL] [Abstract][Full Text] [Related]
29. Extra-virgin olive oil polyphenols inhibit HER2 (erbB-2)-induced malignant transformation in human breast epithelial cells: relationship between the chemical structures of extra-virgin olive oil secoiridoids and lignans and their inhibitory activities on the tyrosine kinase activity of HER2.
Menendez JA; Vazquez-Martin A; Oliveras-Ferraros C; Garcia-Villalba R; Carrasco-Pancorbo A; Fernandez-Gutierrez A; Segura-Carretero A
Int J Oncol; 2009 Jan; 34(1):43-51. PubMed ID: 19082476
[TBL] [Abstract][Full Text] [Related]
30. Potent inhibition of CDC2 kinase activity by the flavonoid L86-8275.
Losiewicz MD; Carlson BA; Kaur G; Sausville EA; Worland PJ
Biochem Biophys Res Commun; 1994 Jun; 201(2):589-95. PubMed ID: 8002990
[TBL] [Abstract][Full Text] [Related]
31. Regulation of mouse preimplantation development: inhibitory effect of genistein, an inhibitor of tyrosine protein phosphorylation, on cleavage of one-cell embryos.
Besterman B; Schultz RM
J Exp Zool; 1990 Oct; 256(1):44-53. PubMed ID: 2401883
[TBL] [Abstract][Full Text] [Related]
32. A lymphocyte-specific protein tyrosine kinase, p56lck, regulates the PMA-induced internalization of CD4.
Yoshida H; Koga Y; Nakamura K; Kimura G; Nomoto K
Biochim Biophys Acta; 1992 Nov; 1137(3):321-30. PubMed ID: 1280163
[TBL] [Abstract][Full Text] [Related]
33. Effect of quercetin on serine/threonine and tyrosine protein kinases.
Srivastava AK; Chiasson JL
Prog Clin Biol Res; 1986; 213():315-8. PubMed ID: 3012582
[No Abstract] [Full Text] [Related]
34. Regulation of the serine-base exchange enzyme system by CD4: effects of monoclonal antibodies, jacalin, interleukin 16 and the HIV membrane protein gp120.
Dumaurier MJ; Pelassy C; Breittmayer JP; Aussel C
Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):49-54. PubMed ID: 9405274
[TBL] [Abstract][Full Text] [Related]
35. Functional characterization of peanut serine/threonine/tyrosine protein kinase: molecular docking and inhibition kinetics with tyrosine kinase inhibitors.
Rudrabhatla P; Rajasekharan R
Biochemistry; 2004 Sep; 43(38):12123-32. PubMed ID: 15379551
[TBL] [Abstract][Full Text] [Related]
36. Differential inhibition of T cell receptor signal transduction and early activation events by a selective inhibitor of protein-tyrosine kinase.
Trevillyan JM; Lu YL; Atluru D; Phillips CA; Bjorndahl JM
J Immunol; 1990 Nov; 145(10):3223-30. PubMed ID: 2172380
[TBL] [Abstract][Full Text] [Related]
37. Expression of p56lck in B-cell neoplasias.
Von Knethen A; Abts H; Kube D; Diehl V; Tesch H
Leuk Lymphoma; 1997 Aug; 26(5-6):551-62. PubMed ID: 9389362
[TBL] [Abstract][Full Text] [Related]
38. Angiogenic oligosaccharides of hyaluronan induce protein tyrosine kinase activity in endothelial cells and activate a cytoplasmic signal transduction pathway resulting in proliferation.
Slevin M; Krupinski J; Kumar S; Gaffney J
Lab Invest; 1998 Aug; 78(8):987-1003. PubMed ID: 9714186
[TBL] [Abstract][Full Text] [Related]
39. Tyrosine kinase inhibitors. 2. Synthesis of 2,2'-dithiobis(1H-indole-3-alkanamides) and investigation of their inhibitory activity against epidermal growth factor receptor and pp60v-src protein tyrosine kinases.
Thompson AM; Fry DW; Kraker AJ; Denny WA
J Med Chem; 1994 Mar; 37(5):598-609. PubMed ID: 7510340
[TBL] [Abstract][Full Text] [Related]
40. Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure-activity relationships.
Ferriola PC; Cody V; Middleton E
Biochem Pharmacol; 1989 May; 38(10):1617-24. PubMed ID: 2730676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
